![igc-ad1 igc pharma](https://investor.igcpharma.com/wp-content/uploads/2024/04/PR-AD_02-min-1024x1024.jpg)
September 8, 2021
IGC Completes its Phase 1 Clinical Trial on Alzheimer’s Patients, Reports Safety and Tolerability
Facebook
Twitter
LinkedIn